In addition, we analyzed the USP22 expression based on the TCGA pan-cancer transcriptomics data (http://gepia2.cancer-pku.cn/#index) and found that USP22 was highly expressed in HCC and cholangiocarcinoma but not in the other cancer types (Supplementary Fig. 2)25. Here, USP22 is linked to hepatocellular carcinoma.